Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Capsoni

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
BMC Musculoskeletal Disorders|February 6, 2016
Arthralgias, fatigue, paresthesias and visceral pain: can joint hypermobility solve the puzzle? A case reportMarco Folci, Franco Capsoni
Arthritis Research & Therapy|October 20, 2006
Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's roleFranco Capsoni, Matteo Longhi, Roberto Weinstein
Arthritis Research & Therapy|October 7, 2005
Primary and secondary autoimmune neutropeniaFranco Capsoni, Piercarlo Sarzi-Puttini, Alberto Zanella
Rheumatology International|May 22, 2010
Fibromuscular dysplasia: a rare disease that can mimic vasculitisFranco Capsoni, Giorgio Poletto, Pier Luigi Giorgetti
Arthritis Research & Therapy|October 10, 2009
Melanocortin peptides inhibit urate crystal-induced activation of phagocytic cellsFranco Capsoni, Anna Maria Ongari, Eva Reali, et al.
Peptides|September 14, 2007
The synthetic melanocortin (CKPV)2 exerts broad anti-inflammatory effects in human neutrophilsFranco Capsoni, Annamaria Ongari, Gualtiero Colombo, et al.
Autoimmunity Reviews|April 13, 2005
Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a reviewFabiola Atzeni, Piercarlo Sarzi-Puttini, Andrea Doria, et al.
Autoimmunity|December 24, 2005
Drug-induced lupus erythematosusPiercarlo Sarzi-Puttini, Fabiola Atzeni, Franco Capsoni, et al.
Annals of the New York Academy of Sciences|August 30, 2005
Autoimmunity and anti-TNF-alpha agentsFabiola Atzeni, Maurizio Turiel, Franco Capsoni, et al.
BMC Musculoskeletal Disorders|June 22, 2015
α-Melanocyte-stimulating-hormone (α-MSH) modulates human chondrocyte activation induced by proinflammatory cytokinesFranco Capsoni, Anna Maria Ongari, Caterina Lonati, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
BMC Musculoskeletal Disorders|February 6, 2016
Arthralgias, fatigue, paresthesias and visceral pain: can joint hypermobility solve the puzzle? A case reportMarco Folci, Franco Capsoni
Arthritis Research & Therapy|October 20, 2006
Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's roleFranco Capsoni, Matteo Longhi, Roberto Weinstein
Arthritis Research & Therapy|October 7, 2005
Primary and secondary autoimmune neutropeniaFranco Capsoni, Piercarlo Sarzi-Puttini, Alberto Zanella
Rheumatology International|May 22, 2010
Fibromuscular dysplasia: a rare disease that can mimic vasculitisFranco Capsoni, Giorgio Poletto, Pier Luigi Giorgetti
Arthritis Research & Therapy|October 10, 2009
Melanocortin peptides inhibit urate crystal-induced activation of phagocytic cellsFranco Capsoni, Anna Maria Ongari, Eva Reali, et al.
Peptides|September 14, 2007
The synthetic melanocortin (CKPV)2 exerts broad anti-inflammatory effects in human neutrophilsFranco Capsoni, Annamaria Ongari, Gualtiero Colombo, et al.
Autoimmunity Reviews|April 13, 2005
Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a reviewFabiola Atzeni, Piercarlo Sarzi-Puttini, Andrea Doria, et al.
Autoimmunity|December 24, 2005
Drug-induced lupus erythematosusPiercarlo Sarzi-Puttini, Fabiola Atzeni, Franco Capsoni, et al.
Annals of the New York Academy of Sciences|August 30, 2005
Autoimmunity and anti-TNF-alpha agentsFabiola Atzeni, Maurizio Turiel, Franco Capsoni, et al.
BMC Musculoskeletal Disorders|June 22, 2015
α-Melanocyte-stimulating-hormone (α-MSH) modulates human chondrocyte activation induced by proinflammatory cytokinesFranco Capsoni, Anna Maria Ongari, Caterina Lonati, et al.
Pageof 2